Australia Medical Cannabis Market
Updated Date: 22 July 2026   |   Report Code: 6986
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Australia Medical Cannabis Market Size, Forecast and Shares 2026

According to Payal Rabde, who specializes in cultivation, production, prescription, and therapeutics use of cannabis-based medicines for managing chronic pain, eplipsy, multiple sclerosis, cancer-related symptoms, and other medical condition, evidence based treatment through regulated prescribing, pharmaceutical manufacturing and patient monitoring, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the Australia medical cannabis market. The global Australia medical cannabis market size was estimated at USD 1.02 billion in 2025 and is predicted to increase from USD 1.17 billion in 2026 to approximately USD 3.99 billion by 2035, expanding at a CAGR of 14.6% from 2026 to 2035. Her analysis highlights the increasing adoption of cannabis-based therapies for chronic pain and neurological disorders, increasing use of prescription medical cannabis for symptom management, growing acceptance of cannabinoid-based medicines in clinical practices, and expanding adoption of medical cannabis for palliative and supportive care. The research also examines the competitive strategies of key industry participants, including, Little Green Pharma, Cann Group, ECS Botanics, Vitura Health, and Australia Natural Therapeutics Group, shaping the future by advancing precision cannabinoid therapies for personalized treatment, expanding pharmaceutical-grade cannabis formulation and delivery systems, integrating AI-driven research for cannabinoid drug development, supporting innovation in controlled-release and non-inhalable cannabis products, and accelerating clinical research on novel cannabinoid-based therapeutics in the global Australia medical cannabis market.

Last Updated : 22 July 2026 Category: Therapeutic Area Insight Code: 6986 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Australia Medical Cannabis Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Compound Type
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Application Insight
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Distribution Channel
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By End User Insights
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Gender
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Patient Age Group
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Australia Medical Cannabis Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Segment 1, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Compound Type
      • By Application
      • By Gender
      • By Distribution Channel
      • By Patient Age Group
      • By End User
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Little Green Pharma
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Cann Group
    • ECS Botanics
    • Vitura Health
    • Australia Natural Therapeutics Group

FAQ's

Answer : The Australia medical cannabis market size was estimated at USD 1.02 billion in 2025 and is predicted to increase from USD 1.17 billion in 2026 to approximately USD 3.99 billion by 2035, expanding at a CAGR of 14.6% from 2026 to 2035.

Answer : The National Academies of Sciences, Engineering, and Medicine, Journal of the American Medical Association, and StatPearls.

Answer : Major Companies include Little Green Pharma, Cann Group, ECS Botanics, Vitura Health, Australia Natural Therapeutics Group.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar